-
Washington U. researchers discover plague's weakness
The scourge of the Middle Ages continues to plague Africa; terrorism another major fear; researchers disable Yersinia pestis by removing a clot-inhibiting protein
-
-
Iomai wins $128 million HHS contract for patch-based flu vaccine
Innoculation method could be mailed to patients; adjuvant stimulants allow the company to stretch out the nation’s vaccine supply; company looks for distribution partners, but many already see MedImmune as the most promising candidate
-
-
Massachusetts researchers add nanotransmitters to microfluidic arrays
Technique used to quickly identify pathogens such as anthrax; cuts down on the size of handheld and static detection devices; waveguide and nanoantennas focus light to a spot size smaller than half its wavelength
-
-
Biophotonics market to emerge in 2011
Experts predict a $2 billion industry in a few years; intrinisc and extrinsic sensors try to prove themselves in the drug industry but with limited success; breakthroughs needed in microarrays before major homeland security applications will be possible
-
-
Raman spectroscopy used to identify counterfeit drugs
Breakthrough approach can identify fakes while inside their packaging; researchers at the Rutherford Appleton Laboratory adjust the collection point a few millimeters in front of the laser signal; tests on paracetamol and ibuprofen prove the concept
-
-
Weather found to be a good predictor of epidemics
NASA climatologists provide Kenyan authorities a four month warning about a Rift Valley Fever outbreak; heat and moisture are strong indicators of a pathogen’s virulence; for countries unable to afford large-scale epidemiological surveys, weather provides a cheaper indicator
-
-
Affymetrix licenses its microarray technology to Tessarae
Tessarae will use the arrays to improve its epidemic monitoring products; authorities believe test will help identify influenza mutations in their infancy; approach relies on multiplexed genotypic signatures rather than phenotypes to identify strains
-
-
British Home Office imposes strict new pathogen controls
Private and university laboratories will now have to inventory their stocks of 100 named viruses and bacteria; government order reports of all employees with access to such stores
-
-
E. coli able to detect arsenic
From foe to friend, mankind’s enemy lends a hand in the fight against arsenic poisoning in the third world; Edinburgh researchers rely on synthetic biology to develop this easy to use, field-portable test
-
-
Microwave ovens shown to kill anthrax
Florida researchers prove a concept already known to housewives worldwide; four minutes with a wet sponge is sufficient to disable spores; technique unlikely to work on dry envelopes
-
-
Lockheed wins $135 million CDC support contract
Company will provide operational and logistical services for various offices with COPTER; office provides strategic direction to CDC on all terrorism preparedness issues
-
-
iJet releases study on business impact of avian flu pandemic
Using data drawn from its World Pandemic monitoring system, research firm lays out preparation strategies for business; free report available by contacting company
-
-
"Home brew" polymerase tests lead to pseudo-epidemics
With commercial tests only now coming to the market, many ad-hoc methods suffer from unknown error rates and high numbers of false positives; whooping cough epidemic at Dartmouth provides an interesting case study; lack of best practices a major concern
-
-
Somark's inkless RFID tattoos could keep troops safe
Yesterday’s attack in Iraq proves uniforms may not be the best way to distinguish friend from foe; technology intended for tracking cattle could prove a lifesaver for humans; passive RFID is perfectly harmless and does not require line of sight to be read
-
-
ICx acquires bio-sensor firm GHC Technologies
Deal follows an earlier acquisition of Griffin Analytical Technologies; GHC an expert in pathogen detection for both infrastructure and city-wide surveillance; industry consolidation continues
-
The long view
What We’ve Learned from Survivors of the Atomic Bombs
Q&A with Dr. Preetha Rajaraman, New Vice Chair for the Radiation Effects Research Foundation in Hiroshima and Nagasaki, Japan.
Combatting the Measles Threat Means Examining the Reasons for Declining Vaccination Rates
Measles was supposedly eradicated in Canada more than a quarter century ago. But today, measles is surging. The cause of this resurgence is declining vaccination rates.
Social Networks Are Not Effective at Mobilizing Vaccination Uptake
The persuasive power of social networks is immense, but not limitless. Vaccine preferences, based on the COVID experience in the United States, proved quite insensitive to persuasion, even through friendship networks.
Vaccine Integrity Project Says New FDA Rules on COVID-19 Vaccines Show Lack of Consensus, Clarity
Sidestepping both the FDA’s own Vaccines and Related Biological Products Advisory Committee and the CDC’s Advisory Committee on Immunization Practices (ACIP), two Trump-appointed FDA leaders penned an opinion piece in the New England Journal of Medicine to announce new, more restrictive, COVID-19 vaccine recommendations. Critics say that not seeking broad input into the new policy, which would help FDA to understand its implications, feasibility, and the potential for unintended consequences, amounts to policy by proclamation.
Are We Ready for a ‘DeepSeek for Bioweapons’?
Anthropic’s Claude 4 is a warning sign: AI that can help build bioweapons is coming, and could be widely available soon. Steven Adler writes that we need to be prepared for the consequences: “like a freely downloadable ‘DeepSeek for bioweapons,’ available across the internet, loadable to the computer of any amateur scientist who wishes to cause mass harm. With Anthropic’s Claude Opus 4 having finally triggered this level of safety risk, the clock is now ticking.”
“Tulsi Gabbard as US Intelligence Chief Would Undermine Efforts Against the Spread of Chemical and Biological Weapons”: Expert
The Senate, along party lines, last week confirmed Tulsi Gabbard as Director of National intelligence. One expert on biological and chemical weapons says that Gabbard’s “longstanding history of parroting Russian propaganda talking points, unfounded claims about Syria’s use of chemical weapons, and conspiracy theories all in efforts to undermine the quality of the community she now leads” make her confirmation a “national security malpractice.”